Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis

Launched by SUN YAT-SEN MEMORIAL HOSPITAL OF SUN YAT-SEN UNIVERSITY · Jul 18, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new diagnostic test that uses artificial intelligence (AI) to help detect cancer spread to lymph nodes, a condition known as lymphatic metastasis. The goal is to see if this AI model can work better than the traditional methods used by pathologists when checking for cancer spread. By comparing the accuracy of the AI with standard reports, researchers hope to improve how cancer evaluations are done in everyday medical practice.

To participate in this trial, individuals need to have cancer and be scheduled for surgery to remove their tumor and nearby lymph nodes. It’s important that they also have complete medical records available. If someone decides not to take part, they will be excluded from the study. Those who join can expect to undergo the usual tests and evaluations, but also to have their results analyzed using this advanced AI model, which could potentially lead to better treatment outcomes in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with cancer, undergoing radical tumor resection and lymph node dissection.
• • Patients with complete clinical and pathological information.
• Exclusion Criteria:
• • The patient refused to participate in this diagnostic test.